Syneos Health, Inc.
SYNH · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $4,369 | $3,680 | $3,775 | $4,844 |
| - Cash | $82 | $111 | $112 | $170 |
| + Debt | $2,895 | $2,880 | $2,899 | $3,049 |
| Enterprise Value | $7,182 | $6,449 | $6,561 | $7,723 |
| Revenue | $1,366 | $1,357 | $1,360 | $1,336 |
| % Growth | 0.7% | -0.2% | 1.8% | – |
| Gross Profit | $295 | $268 | $318 | $318 |
| % Margin | 21.6% | 19.8% | 23.4% | 23.8% |
| EBITDA | $98 | $88 | $123 | $186 |
| % Margin | 7.2% | 6.5% | 9.1% | 13.9% |
| Net Income | $1 | -$72 | $56 | $87 |
| % Margin | 0.1% | -5.3% | 4.1% | 6.5% |
| EPS Diluted | 0.01 | -0.7 | 0.54 | 0.84 |
| % Growth | 101.4% | -229.6% | -35.7% | – |
| Operating Cash Flow | -$34 | $30 | $124 | $132 |
| Capital Expenditures | -$18 | -$28 | -$24 | -$22 |
| Free Cash Flow | -$52 | $3 | $100 | $110 |